Fundraising FoxMedeasy
Bangladesh, BD · 7 known investors
Find your way into Medeasy
Sign up to see every warm intro you have to Medeasy
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Medeasy team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Brintop F 5% Topical Solution is a dual-action hair loss treatment containing minoxidil and finasteride for adult men. The product is sold through MedEasy's pharmacy platform.
Also known as MedEasy
Founders & leadership
Investors · 7
How we know: the company's own site · Not right? Tell us
Also in the syndicate · 4
Company profile
researched Aug 2026MedEasy is an online pharmacy and digital healthcare platform based in Dhaka, Bangladesh. It delivers authentic medicines to customers' homes nationwide and connects users with licensed doctors for video consultations, positioning itself around the roughly 30 million people living with chronic health conditions in Bangladesh.
The company operates a proprietary inventory management system and a decentralized distribution network, and sources directly from manufacturers. Planned additions announced alongside its 2023 seed round include a subscription-based feature, a digital vital monitoring system, and an appointment-booking marketplace. Longer-term plans described by the founder include a booking.com-style healthcare services marketplace, a natural-language chat interface, and alternative financial products for healthcare financing.
Founding story
Founder and CEO Arefin Zaman, a computer science graduate of RUET (2017) who worked as a machine learning engineer and led the machine learning team at SociunAI, was motivated by his father's chronic illness. In late 2019 he started DoctorBondhu, a project to digitize patient records and enable video consultations for hospitals and clinics; when monetization proved difficult and COVID-19 arrived, it pivoted to a business-to-consumer telemedicine marketplace. After his father died of COVID-19 in mid-2020, Zaman committed fully to the MedEasy mission.
Business model
MedEasy sells medicines through an online pharmacy with home delivery and offers doctor video consultations, working directly with manufacturers to source medication. A subscription-based feature and an appointment-booking marketplace were announced as planned offerings.
Revenue is generated from online medicine sales and delivery and from doctor consultation services, with a subscription feature and healthcare services marketplace planned.
Traction
By September 2023 the platform reported more than 150,000 users gained within about two years of inception, over 185,000 medicine orders delivered in the prior two years, an 80% customer retention rate (up from 10% before the pharmacy pivot), and a 96% medication fulfillment rate.
Latest developments
In September 2023 MedEasy closed a $750,000 seed round led by Seedstars International Ventures, Doha Tech Angels, Startup Bangladesh Limited, Accelerating Asia, and nVentures, with angel investors participating. Proceeds were allocated to customer acquisition, operational refinement, platform features, and R&D, alongside plans for a subscription feature, digital vital monitoring, and an appointment-booking marketplace.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
Described in Bangladeshi press as one of the leading players in the country's online pharmacy sector, addressing a market sized at $3 billion, in a context where about 70% of healthcare costs are paid out of pocket and 64% of that goes to medications.
According to the company, its inventory management system and decentralized distribution network cut delivery times to a quarter of those of competitors, and direct manufacturer relationships support a 96% medication fulfillment rate, compared with traditional pharmacies that often cannot fill complete prescriptions. Investors cited its focus on the chronic patient segment and a data-driven approach.
Technology
The platform combines a proprietary inventory management system with a decentralized distribution network and inventory tracking, supporting medicine ordering and delivery plus video consultations with licensed doctors. Planned technology work includes a digital vital monitoring system and a natural language chat interface.
Go-to-market
Direct-to-consumer digital platform for medicine ordering and doctor consultations, with nationwide home delivery; seed proceeds were earmarked for customer acquisition, operations, platform features, and R&D.
Consumers in Bangladesh, with particular focus on the approximately 30 million people with chronic health conditions who require recurring medication and consultations.
Geography
Headquartered in Dhaka, Bangladesh, with nationwide doctor video consultations and medicine home delivery across the country.
History
The venture began as DoctorBondhu in late 2019 before pivoting to a consumer telemedicine marketplace during the pandemic. MedEasy itself started roughly two years before September 2023. Facing low early customer retention, the company added an online pharmacy, which lifted retention substantially. In September 2023 it announced a $750,000 seed round backed by international and Bangladeshi investors.
Compiled by commissioned research from 5 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 1
launches, deals, and filingsMedEasy announced a $750,000 seed round with Seedstars International Ventures, Doha Tech Angels, Startup Bangladesh Limited, Accelerating Asia, nVentures and angel investors, to fund customer acquisition, operations, platform features and R&D.
$750K source ↗
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 5
primary sources listed
- Bangladeshi startup MedEasy raises $750K in seed funding | The Daily Starthedailystar.net · web
5 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Medeasy do?
- MedEasy is a Dhaka-based online pharmacy and telemedicine platform serving chronic-disease patients in Bangladesh.
- Who founded Medeasy?
- Medeasy was founded by Arefin Zaman, Md Nazmul Hossain.
- Who are Medeasy's investors?
- Medeasy's investors include Startup Bangladesh, Doha Tech Angels, Accelerating Asia.
- Where is Medeasy headquartered?
- Medeasy is headquartered in Bangladesh, BD.